Uric acid increases erythrocyte aggregation: Implications for cardiovascular disease

Area of Science:

• Biochemistry
• Hematology
• Cardiovascular Science

Background:

• Uric acid's role in atherosclerotic cardiovascular disease (ASCVD) is debated.
• The precise mechanism linking uric acid to ASCVD remains unclear.

Purpose of the Study:

• To investigate if uric acid induces erythrocyte aggregation.
• To test the hypothesis that uric acid, as an anion, causes red blood cell clumping.

Main Methods:

• Normal and IgG-coated erythrocytes were incubated with uric acid (14.8 mg/dL).
• Erythrocyte aggregation was assessed microscopically.
• Control groups without added uric acid were used.

Main Results:

• Uric acid induced aggregation in normal erythrocytes (up to 30 cells/aggregate).
• Greater aggregation occurred with IgG-coated erythrocytes.
• Aggregation was minimal in control samples.

Conclusions:

• Uric acid directly causes erythrocyte aggregation.
• This aggregation is likely due to reduced erythrocyte zeta potential.
• Increased blood viscosity from aggregation may elevate atherothrombosis risk, positioning hyperuricemia as a potential ASCVD risk factor.